First Light Asset Management as of Dec. 31, 2016
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 54 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
NeoGenomics (NEO) | 9.7 | $22M | 2.6M | 8.57 | |
AtriCure (ATRC) | 8.1 | $18M | 939k | 19.57 | |
Akorn | 5.1 | $12M | 535k | 21.83 | |
Oxford Immunotec Global | 4.9 | $11M | 748k | 14.95 | |
LHC | 4.4 | $10M | 220k | 45.70 | |
Array BioPharma | 3.9 | $8.8M | 1.0M | 8.79 | |
Harvard Bioscience (HBIO) | 3.7 | $8.4M | 2.7M | 3.05 | |
Immunomedics | 3.7 | $8.4M | 2.3M | 3.67 | |
HealthStream (HSTM) | 3.4 | $7.6M | 304k | 25.05 | |
Entellus Medical Cm | 3.3 | $7.4M | 391k | 18.97 | |
Enzo Biochem (ENZ) | 3.1 | $7.0M | 1.0M | 6.94 | |
NxStage Medical | 2.9 | $6.5M | 247k | 26.21 | |
Shire | 2.8 | $6.3M | 37k | 170.37 | |
Teligent | 2.8 | $6.3M | 958k | 6.61 | |
K2m Group Holdings | 2.4 | $5.5M | 274k | 20.04 | |
Veracyte (VCYT) | 2.4 | $5.4M | 692k | 7.74 | |
Amedisys (AMED) | 2.2 | $5.0M | 117k | 42.63 | |
Sage Therapeutics (SAGE) | 2.1 | $4.8M | 94k | 51.06 | |
Spectranetics Corporation | 2.0 | $4.5M | 184k | 24.50 | |
Bluebird Bio (BLUE) | 1.9 | $4.4M | 71k | 61.70 | |
Medicines Company | 1.9 | $4.3M | 128k | 33.94 | |
Ligand Pharmaceuticals In (LGND) | 1.8 | $4.2M | 41k | 101.60 | |
LeMaitre Vascular (LMAT) | 1.8 | $4.1M | 160k | 25.34 | |
Bio-techne Corporation (TECH) | 1.7 | $4.0M | 39k | 102.83 | |
Model N (MODN) | 1.5 | $3.4M | 383k | 8.85 | |
Alkermes (ALKS) | 1.5 | $3.4M | 61k | 55.57 | |
Aratana Therapeutics | 1.3 | $2.9M | 410k | 7.18 | |
Physicians Realty Trust | 1.3 | $2.9M | 153k | 18.96 | |
BioMarin Pharmaceutical (BMRN) | 1.2 | $2.6M | 32k | 82.84 | |
Nanostring Technologies (NSTGQ) | 1.1 | $2.6M | 116k | 22.30 | |
Ionis Pharmaceuticals (IONS) | 1.0 | $2.4M | 50k | 47.84 | |
iShares NASDAQ Biotechnology Index (IBB) | 0.9 | $2.1M | 7.9k | 265.29 | |
Streamline Health Solutions (STRM) | 0.9 | $2.0M | 1.6M | 1.25 | |
Tearlab Corp | 0.8 | $1.7M | 3.4M | 0.52 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $1.7M | 23k | 73.67 | |
RTI Biologics | 0.7 | $1.6M | 506k | 3.25 | |
Quidel Corporation | 0.7 | $1.6M | 75k | 21.41 | |
Celgene Corporation | 0.7 | $1.6M | 14k | 115.75 | |
Powershares Etf Tr Ii s^p smcp hc po | 0.6 | $1.3M | 17k | 73.07 | |
Macrogenics (MGNX) | 0.6 | $1.3M | 62k | 20.44 | |
Health Care SPDR (XLV) | 0.6 | $1.3M | 18k | 68.97 | |
iShares Dow Jones US Medical Dev. (IHI) | 0.4 | $1.0M | 7.6k | 133.11 | |
SPDR S&P Biotech (XBI) | 0.3 | $712k | 12k | 59.16 | |
Chembio Diagnostics | 0.2 | $519k | 76k | 6.80 | |
Iradimed (IRMD) | 0.2 | $437k | 39k | 11.10 | |
St. Jude Medical | 0.1 | $314k | 3.9k | 80.29 | |
Pfizer (PFE) | 0.1 | $278k | 8.6k | 32.48 | |
Sanofi-Aventis SA (SNY) | 0.1 | $272k | 6.7k | 40.48 | |
Agile Therapeutics | 0.1 | $264k | 46k | 5.70 | |
Johnson & Johnson (JNJ) | 0.1 | $252k | 2.2k | 115.44 | |
Novartis (NVS) | 0.1 | $260k | 3.6k | 72.79 | |
Merck & Co (MRK) | 0.1 | $253k | 4.3k | 58.92 | |
Abbvie (ABBV) | 0.1 | $260k | 4.2k | 62.52 | |
Avinger | 0.1 | $164k | 44k | 3.69 |